Ingegerd Hellström

22.7k total citations · 5 hit papers
293 papers, 18.0k citations indexed

About

Ingegerd Hellström is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ingegerd Hellström has authored 293 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Immunology, 116 papers in Radiology, Nuclear Medicine and Imaging and 102 papers in Oncology. Recurrent topics in Ingegerd Hellström's work include Monoclonal and Polyclonal Antibodies Research (111 papers), Immunotherapy and Immune Responses (109 papers) and Immune Cell Function and Interaction (51 papers). Ingegerd Hellström is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (111 papers), Immunotherapy and Immune Responses (109 papers) and Immune Cell Function and Interaction (51 papers). Ingegerd Hellström collaborates with scholars based in United States, Germany and Sweden. Ingegerd Hellström's co-authors include Karl Erik Hellström, K E Hellström, Hans Sjögren, K. E. Hellström, Joseph P. Brown, Glenn A. Warner, Lieping Chen, George E. Pierce, S. C. Bansal and James P.S. Yang and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ingegerd Hellström

292 papers receiving 16.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

2003 582 citations Ingegerd Hellström, Martha Hayden-Ledbetter et al. PubMed profile →
Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

1971 560 citations Hans Sjögren, Ingegerd Hellström et al. profile →
Demonstration of cell‐mediated immunity to human neoplasms of various histological types

1971 545 citations Ingegerd Hellström, K. E. Hellström et al. profile →
Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor Antigens

1974 509 citations Karl Erik Hellström, Ingegerd Hellström Advances in immunology profile →
Cellular Immunity Against Tumor Antigens

1969 372 citations Karl Erik Hellström, Ingegerd Hellström profile →

Peers

Countries citing papers authored by Ingegerd Hellström

Since Specialization

Citations

This map shows the geographic impact of Ingegerd Hellström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingegerd Hellström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingegerd Hellström more than expected).

Fields of papers citing papers by Ingegerd Hellström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingegerd Hellström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingegerd Hellström. The network helps show where Ingegerd Hellström may publish in the future.

Co-authorship network of co-authors of Ingegerd Hellström

This figure shows the co-authorship network connecting the top 25 collaborators of Ingegerd Hellström. A scholar is included among the top collaborators of Ingegerd Hellström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingegerd Hellström. Ingegerd Hellström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	From the Hellstrom paradox toward cancer cure 2019 ·Progress in molecular biology and translational science ·Karl Erik Hellström, Ingegerd Hellström	13
2	Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies 2014 ·Clinical Cancer Research ·Min Dai, (unknown), Ingegerd Hellström, Karl Erik Hellström	44
3	Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity. 2003 ·PubMed ·Mary L. Disis, Nathalie Scholler, Amber Dahlin, (unknown), Keith L. Knutson, K E Hellström, Ingegerd Hellström	14
4	Cutting Edge: CD83 Regulates the Development of Cellular Immunity 2002 ·The Journal of Immunology ·Nathalie Scholler, Martha Hayden-Ledbetter, Amber Dahlin, Ingegerd Hellström, Karl Erik Hellström, Jeffrey A. Ledbetter	103
5	Overexpression of HER-2 in ovarian carcinomas. 2001 ·PubMed ·Ingegerd Hellström, Gary E. Goodman, (unknown), Yu Yang, K. E. Hellström	107
6	CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells 2001 ·The Journal of Immunology ·Nathalie Scholler, Martha Hayden-Ledbetter, (unknown), Ingegerd Hellström, Jeffrey A. Ledbetter	95
7	Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma. 1998 ·PubMed ·(unknown), (unknown), Sarah Bacus, (unknown), (unknown), Ingegerd Hellström, (unknown), (unknown)	36
8	B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes. 1996 ·The Journal of Experimental Medicine ·Janet Johnston, Alison R. Malacko, (unknown), Patrick O. McGowan, Ingegerd Hellström, K E Hellström, Hans Marquardt, Lieping Chen	82
9	Cloning and Expression of the Gene for the Melanoma-Associated ME20 Antigen 1994 ·DNA and Cell Biology ·Grace A. Maresh, John Marken, Michael Neubauer, Alejandro Aruffo, Ingegerd Hellström, Karl Erik Hellström, Hans Marquardt	22
10	Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. 1994 ·The Journal of Experimental Medicine ·Lieping Chen, Patrick O. McGowan, S Ashe, James A. Johnston, Yongsheng Li, Ingegerd Hellström, K. E. Hellström	409
11	Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates 1993 ·Science ·Pamela A. Trail, David Willner, Shirley J. Lasch, Arris J. Henderson, Sandra J. Hofstead, Anna Maria Casazza, Raymond A. Firestone, Ingegerd Hellström, K E Hellström	414
12	Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy 1991 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·Sally J. DeNardo, L.F. O'Grady, Daniel J. Macey, Linda A. Kroger, Gerald L. DeNardo, Kathleen R. Lamborn, Nicolas Lévy, (unknown), Ingegerd Hellström, (unknown)	27
13	Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates 1991 ·Bioconjugate Chemistry ·Peter D. Senter, P. P. Su, Tohoru Katsuragi, Takuo Sakai, W L Cosand, Ingegerd Hellström, Karl Erik Hellström	62
14	Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide 1990 ·Cancer Immunology Immunotherapy ·David E. Kerr, Peter D. Senter, William Burnett, David L. Hirschberg, Ingegerd Hellström, Karl Erik Hellström	49
15	Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen. 1989 ·PubMed ·Maria Kahn, Ingegerd Hellström, (unknown), Karl Erik Hellström	13
16	Melanoma localization in nude mice with monoclonal Fab against p97. 1985 ·PubMed ·Paul L. Beaumier, Kenneth A. Krohn, Jorge A. Carrasquillo, Janet F. Eary, Ingegerd Hellström, Karl Erik Hellström, Wil B. Nelp, Steven M. Larson	37
17	Workshop on Monoclonal Antibodies to Human Melanoma-Associated Antigens: Findings of the Seattle Group 1982 ·Hybridoma ·Ingegerd Hellström, Joseph P. Brown, Karl Erik Hellström	5
18	Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor Antigens breakdown → 1974 ·Advances in immunology ·Karl Erik Hellström, Ingegerd Hellström	509
19	IN VITRO DEMONSTRATION OF HUMORAL AND CELL-BOUND IMMUNITY AGAINST COMMON SPECIFIC TRANSPLANTATION ANTIGEN(S) OF ADENOVIRUS 12-INDUCED MOUSE AND HAMSTER TUMORS 1967 ·The Journal of Experimental Medicine ·Ingegerd Hellström, Hans Sjögren	45
20	Transplantation of Polyoma Virus-induced Tumors in Mice 1961 ·Cancer Research ·Hans Olof Sjögren, Ingegerd Hellström, George Klein	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact